Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19

被引：1
|
作者：
Borgoyakova, M. B. [1 ]
Karpenko, L. I. [1 ]
Merkulyeva, I. A. [1 ]
Shcherbakov, D. N. [1 ]
Rudometov, A. P. [1 ]
Starostina, E. V. [1 ]
Shanshin, D. V. [1 ]
Isaeva, A. A. [1 ]
Nesmeyanova, V. S. [1 ]
Volkova, N. V. [1 ]
Belenkaya, S. V. [1 ]
Volosnikova, E. A. [1 ]
Zadorozhny, A. M. [1 ]
Orlova, L. A. [1 ]
Zaykovskaya, A. V. [1 ]
Pyankov, O. V. [1 ]
Bazhan, S. I. [1 ]
Ilyichev, A. A. [1 ]
机构：
[1] Fed Serv Oversight Consumer Protect & Welf, State Res Ctr Virol & Biotechnol VECTOR, Koltsov, Novosibirsk Reg, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2022年 / 174卷 / 02期
关键词：
SARS-CoV-2; DNA vaccines; subunit vaccines; DNA; protein vaccines; immune response;
D O I：
10.1007/s10517-023-05682-9
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
During the COVID-19 pandemic, the development of prophylactic vaccines, including those based on new platforms, became highly relevant. One such platform is the creation of vaccines combining DNA and protein components in one construct. For the creation of DNA vaccine, we chose the full-length spike protein (S) of the SARS-CoV-2 virus and used the recombinant receptor-binding domain (RBD) of the S protein produced in CHO-K1 cells as a protein component. The immunogenicity of the developed combined vaccine and its individual components was compared and the contribution of each component to the induction of the immune response was analyzed. The combined DNA/protein vaccine possesses the advantages of both underlying approaches and is capable of inducing both humoral (similar to subunit vaccines) and cellular (similar to DNA vaccines) immunity.
引用
收藏
页码：246 / 249
页数：4
相关论文
共 50 条
  • [41] Designer protein against covid-19?
    Benestad, Haakon B.
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (04) : 342 - 342
  • [42] Comparative immunogenicity of mRNA and inactivated vaccines against COVID-19
    Lim, Wey Wen
    Mak, Loretta
    Leung, Gabriel M.
    Cowling, Benjamin J.
    Peiris, Malik
    LANCET MICROBE, 2021, 2 (09): : E423 - E423
  • [43] IMMUNOGENICITY OF A HETEROLOGOUS INACTIVATED AND mRNA COVID-19 COMBINATION VACCINE REGIMEN
    Wanlapakorn, Nasamon
    Suntronwong, Nungruthai
    Phowatthanasathian, Harit
    Yorsaeng, Ritthideach
    Kanokudom, Sitthichai
    Assawakosri, Suvichada
    Sudhinaraset, Natthinee
    Poovorawan, Yong
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2023, 54 (04) : 167 - 181
  • [44] Safety and immunogenicity of mRNA COVID-19 vaccine in inpatients with muscular dystrophy
    Saito, Tomoko
    Saito, Toshio
    Hashimoto, Hiroya
    Ogata, Katsuhisa
    Kobayashi, Michio
    Takada, Hiroto
    Kuru, Satoshi
    Kimura, Takashi
    Nakamura, Akinori
    Matsumura, Tsuyoshi
    MUSCLE & NERVE, 2023, 67 (02) : 117 - 123
  • [45] Safety and Immunogenicity of COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases
    Colmegna, Ines
    Useche, Mariana
    Rampakakis, Emmanouil
    Amiable, Nathalie
    Rollet-Labelle, Emmanuelle
    Bessette, Louis
    Costa, Jo-Anne
    Dionne, Marc
    Fitzcharles, Mary-Ann
    Hazel, Elizabeth
    McCormack, Deirdre
    Michou, Laetitia
    Panopalis, Pantelis
    Langlois, Marc-Andre
    Bernatsky, Sasha
    Fortin, Paul
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 759 - 760
  • [46] COVID-19 Vaccine Immunogenicity, Effectiveness and Safety in Frail Older Adults
    Chou, Hsiao-Hui
    Tseng, Hsiang-Kuang
    Hwang, Lee-Ching
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2022, 16 (03) : 175 - 179
  • [47] Evaluating the Immunogenicity of an Intranasal Microparticle Combination Vaccine for COVID-19 and Influenza
    Vijayanand, Sharon
    Patil, Smital
    Bagwe, Priyal
    Singh, Revanth
    Adediran, Emmanuel
    D'Souza, Martin J.
    VACCINES, 2025, 13 (03)
  • [48] Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers
    Benjamanukul, Saovanee
    Traiyan, Sasiwimon
    Yorsaeng, Ritthideach
    Vichaiwattana, Preeyaporn
    Sudhinaraset, Natthinee
    Wanlapakorn, Nasamon
    Poovorawan, Yong
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1442 - 1449
  • [49] Covid-19 vaccine immunogenicity in people living with HIV-1
    Nault, Lauriane
    Marchitto, Lorie
    Goyette, Guillaume
    Tremblay-Sher, Daniel
    Fortin, Claude
    Martel-Laferriere, Valerie
    Trottier, Benoit
    Richard, Jonathan
    Durand, Madeleine
    Kaufmann, Daniel
    Finzi, Andres
    Tremblay, Cecile
    VACCINE, 2022, 40 (26) : 3633 - 3637
  • [50] Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates
    Stepanova, Ekaterina
    Isakova-Sivak, Irina
    Matyushenko, Victoria
    Mezhenskaya, Daria
    Kudryavtsev, Igor
    Kostromitina, Arina
    Chistiakova, Anna
    Rak, Alexandra
    Bazhenova, Ekaterina
    Prokopenko, Polina
    Kotomina, Tatiana
    Donina, Svetlana
    Novitskaya, Vlada
    Sivak, Konstantin
    Karal-Ogly, Dzhina
    Rudenko, Larisa
    VACCINES, 2024, 12 (10)
12345